Never-smoker East Asian females have a tendency to develop adenocarcinoma, and these never-smokers exhibit higher treatment response rates to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), such as gefitinib and erlotinib, than those with a history of tobacco smoking [6]. Here, EGFR is linked to adenocarcinoma.